Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Santhera Pharmaceuticals (SPHDF) Q3 2025 Earnings
SPHDF
23
Sep
Confirmed
Q2 2024
Q3 2024
Q2 2025
Q3 2025
-3.83
-3.05
-2.28
-1.5
Details
Expected EPS
N/A
Actual EPS
-3.831616
Surprise EPS
-3.83
Surprise Percent
+∞%
Description
Santhera Pharmaceuticals (SPHDF) has reported earnings of -3.831616 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login